United Therapeutics Corp (UTHR) Tops Q2 EPS Views
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $499.73 --0%
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
GNLN, AFIB, USDP, More
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
GNLN, AFIB, USDP, More
Join SI Premium – FREE
United Therapeutics Corp (NASDAQ: UTHR) reported Q2 EPS of $1.49, $0.96 better than the analyst estimate of $0.53. Revenue for the quarter came in at $183.75 million versus the consensus estimate of $180.84 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Global (PARA) Tops Q2 EPS by 480c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Helius Medical Technologies (HSDT) Misses Q2 EPS by 31c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
